Data by Company within Biotechnology & Pharmaceuticals Industry
|
|
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
Company |
(Millions) |
(Millions) |
(Millions) |
Number |
Amgen Inc |
$ 145,687 |
$ 28,190 |
$ 6,717 |
24,200 |
Gilead Sciences Inc |
$ 92,226 |
$ 27,116 |
$ 5,613 |
14,400 |
Seagen Inc |
$ 43,034 |
$ 2,300 |
$ -750 |
2,700 |
Moderna Inc |
$ 39,861 |
$ 6,848 |
$ -4,714 |
2,700 |
Biogen Inc |
$ 31,963 |
$ 9,836 |
$ 1,162 |
9,610 |
Argenx se |
$ 19,661 |
$ 856 |
$ -710 |
- |
Neurocrine Biosciences Inc |
$ 14,096 |
$ 1,887 |
$ 250 |
1,000 |
Bio techne Corp |
$ 11,505 |
$ 1,143 |
$ 224 |
3,000 |
Repligen Corp |
$ 11,031 |
$ 670 |
$ 116 |
1,170 |
Qiagen N v |
$ 10,180 |
$ 1,901 |
$ 341 |
5,700 |
Exelixis Inc |
$ 7,406 |
$ 1,830 |
$ 465 |
566 |
Vaxcyte Inc |
$ 6,918 |
- |
$ -300 |
- |
Crispr Therapeutics Ag |
$ 5,676 |
$ 170 |
$ -354 |
- |
Abcam Plc |
$ 5,511 |
- |
$ 0 |
- |
Halozyme Therapeutics Inc |
$ 5,413 |
$ 829 |
$ 282 |
3,011 |
Krystal Biotech Inc |
$ 4,724 |
- |
$ 11 |
- |
Immunovant Inc |
$ 4,375 |
- |
$ -243 |
- |
Orchard Therapeutics Plc |
$ 3,814 |
$ 22 |
$ -73 |
- |
Revolution Medicines Inc |
$ 3,380 |
$ 30 |
$ -331 |
- |
Arcellx Inc |
$ 3,348 |
- |
$ -130 |
- |
Iovance Biotherapeutics Inc |
$ 3,296 |
- |
$ -444 |
- |
Springworks Therapeutics Inc |
$ 3,057 |
- |
$ -348 |
- |
Immunocore Holdings Plc |
$ 2,960 |
- |
$ 0 |
- |
Denali Therapeutics Inc |
$ 2,752 |
$ 341 |
$ 0 |
340 |
Jasper Therapeutics Inc |
$ 2,728 |
- |
$ -61 |
- |
Apogee Therapeutics inc |
$ 2,698 |
- |
$ 0 |
- |
Beam Therapeutics Inc |
$ 2,692 |
$ 82 |
$ -314 |
- |
Immunitybio inc |
$ 2,607 |
$ 1 |
$ -459 |
- |
Recursion Pharmaceuticals Inc |
$ 2,371 |
$ 45 |
$ -328 |
- |
Ginkgo Bioworks Holdings Inc |
$ 2,126 |
$ 315 |
$ -855 |
- |
Kymera Therapeutics Inc |
$ 2,031 |
$ 67 |
$ -103 |
- |
Outlook Therapeutics Inc |
$ 2,026 |
- |
$ -51 |
- |
Vericel Corporation |
$ 2,009 |
$ 198 |
$ -3 |
- |
Twist Bioscience Corporation |
$ 1,945 |
$ 262 |
$ -206 |
750 |
Adaptimmune Therapeutics Plc |
$ 1,860 |
$ 66 |
$ -114 |
- |
Sana Biotechnology Inc |
$ 1,786 |
- |
$ -280 |
- |
Ambrx Biopharma Inc |
$ 1,743 |
$ 9 |
$ -134 |
- |
Mesoblast Ltd |
$ 1,707 |
$ 8 |
$ -82 |
- |
Inhibrx Inc |
$ 1,647 |
$ 2 |
$ -241 |
- |
Instil Bio Inc |
$ 1,574 |
$ 1 |
$ -197 |
- |
Opthea Limited |
$ 1,500 |
$ 0 |
$ -143 |
- |
Vir Biotechnology Inc |
$ 1,431 |
$ 86 |
$ -615 |
- |
Precision Biosciences Inc |
$ 1,351 |
$ 52 |
$ -74 |
- |
4d Molecular Therapeutics Inc |
$ 1,311 |
$ 22 |
$ -96 |
- |
Adma Biologics Inc |
$ 1,290 |
$ 258 |
$ -28 |
256 |
Autolus Therapeutics Plc |
$ 1,080 |
$ 0 |
$ -149 |
- |
Scholar Rock Holding Corp |
$ 1,064 |
$ 47 |
$ -159 |
- |
Curis Inc |
$ 981 |
$ 10 |
$ -47 |
- |
Regenxbio Inc |
$ 980 |
$ 99 |
$ -261 |
300 |
Biocryst Pharmaceuticals Inc |
$ 973 |
$ 331 |
$ -227 |
192 |
Relay Therapeutics Inc |
$ 917 |
$ 26 |
$ -327 |
- |
Tarsus Pharmaceuticals Inc |
$ 900 |
$ 17 |
$ -136 |
- |
Valneva Se |
$ 892 |
$ 390 |
$ -82 |
550 |
Cabaletta Bio Inc |
$ 799 |
- |
$ -62 |
- |
Icosavax Inc |
$ 766 |
$ 1 |
$ -97 |
- |
Vectivbio Holding Ag |
$ 745 |
$ 27 |
$ -94 |
- |
Fusion Pharmaceuticals Inc |
$ 735 |
$ 2 |
$ 84 |
- |
Aerie Pharmaceuticals Inc |
$ 729 |
$ 214 |
$ -37 |
259 |
Fate Therapeutics Inc |
$ 694 |
$ 106 |
$ -173 |
208 |
Hillevax Inc |
$ 677 |
- |
$ -108 |
- |
Neumora Therapeutics Inc |
$ 661 |
- |
$ 0 |
- |
Cullinan Oncology Inc |
$ 655 |
- |
$ -157 |
2 |
Tscan Therapeutics Inc |
$ 648 |
$ 17 |
$ -88 |
- |
Prime Medicine Inc |
$ 638 |
- |
$ 0 |
- |
Allogene Therapeutics inc |
$ 600 |
$ 0 |
$ -340 |
- |
Editas Medicine Inc |
$ 586 |
$ 78 |
$ -153 |
- |
Replimune Group Inc |
$ 552 |
- |
$ -210 |
- |
Novavax inc |
$ 518 |
$ 984 |
$ -545 |
370 |
Alector Inc |
$ 504 |
$ 96 |
$ -141 |
155 |
Mymetics Corporation |
$ 486 |
$ 1 |
$ -14 |
- |
Adaptive Biotechnologies Corporation |
$ 460 |
$ 180 |
$ -196 |
645 |
C4 Therapeutics Inc |
$ 406 |
$ 21 |
$ -132 |
- |
Surrozen Inc |
$ 406 |
- |
$ -35 |
- |
Voyager Therapeutics Inc |
$ 405 |
$ 250 |
$ 132 |
- |
Caribou Biosciences Inc |
$ 386 |
$ 34 |
$ -102 |
- |
Freeline Therapeutics Holdings Plc |
$ 384 |
- |
$ -140 |
- |
Iteos Therapeutics Inc |
$ 367 |
$ 128 |
$ -62 |
97 |
Invivyd Inc |
$ 364 |
- |
$ -170 |
- |
Humacyte Inc |
$ 363 |
- |
$ -89 |
- |
Tenaya Therapeutics Inc |
$ 356 |
- |
$ -128 |
- |
Meiragtx Holdings Plc |
$ 350 |
$ 14 |
$ -84 |
- |
Monte Rosa Therapeutics Inc |
$ 334 |
- |
$ -133 |
- |
Oyster Point Pharma Inc |
$ 300 |
$ 20 |
$ -235 |
- |
Kodiak Sciences Inc |
$ 297 |
- |
$ -271 |
- |
Compass Therapeutics Inc |
$ 287 |
- |
$ -41 |
- |
Century Therapeutics inc |
$ 286 |
$ 2 |
$ -137 |
- |
Gritstone Bio Inc |
$ 285 |
$ 10 |
$ -71 |
- |
Sab Biotherapeutics Inc |
$ 283 |
$ 4 |
$ -27 |
- |
Poseida Therapeutics Inc |
$ 281 |
$ 52 |
$ -132 |
- |
Sophia Genetics Sa |
$ 280 |
$ 62 |
$ -79 |
- |
Aura Biosciences Inc |
$ 271 |
- |
$ -71 |
- |
Solid Biosciences Inc |
$ 268 |
$ 15 |
$ -91 |
- |
Taysha Gene Therapies Inc |
$ 268 |
$ 14 |
$ -215 |
- |
Ocugen Inc |
$ 264 |
- |
$ -76 |
- |
Sutro Biopharma Inc |
$ 237 |
$ 49 |
$ -172 |
- |
Compugen Ltd |
$ 231 |
$ 8 |
$ -34 |
- |
Cardiff Oncology inc |
$ 231 |
$ 3 |
$ -23 |
- |
Checkmate Pharmaceuticals Inc |
$ 227 |
- |
$ -63 |
- |
Eiger Biopharmaceuticals Inc |
$ 226 |
$ 15 |
$ -87 |
- |
Acumen Pharmaceuticals Inc |
$ 216 |
- |
$ -49 |
- |
Coherus Biosciences inc |
$ 209 |
$ 257 |
$ -238 |
650 |
Black Diamond Therapeutics Inc |
$ 206 |
- |
$ -82 |
- |
Agenus Inc |
$ 206 |
$ 101 |
$ -283 |
- |
Lineage Cell Therapeutics Inc |
$ 205 |
$ 9 |
$ -23 |
- |
La Jolla Pharmaceutical Company |
$ 200 |
$ 46 |
$ 4 |
- |
Inmune Bio Inc |
$ 198 |
$ 0 |
$ -27 |
- |
Omega Therapeutics Inc |
$ 194 |
$ 3 |
$ -108 |
- |
Scilex Holding Company |
$ 192 |
$ 71 |
$ -117 |
- |
Innate Pharma Sa |
$ 190 |
$ 65 |
$ -65 |
- |
Graphite Bio Inc |
$ 185 |
- |
$ -126 |
- |
X4 Pharmaceuticals Inc |
$ 182 |
- |
$ -111 |
- |
Apeiron Capital Investment Corp |
$ 180 |
- |
$ 7 |
- |
Adverum Biotechnologies Inc |
$ 179 |
$ 2 |
$ -117 |
- |
Genfit S a |
$ 174 |
$ 30 |
$ -27 |
194 |
Tourmaline Bio Inc |
$ 171 |
- |
$ -63 |
- |
Vaxart Inc |
$ 168 |
$ 7 |
$ -82 |
- |
Bluebird Bio Inc |
$ 157 |
$ 22 |
$ -91 |
- |
Xtant Medical Holdings Inc |
$ 149 |
$ 77 |
$ 3 |
- |
Elevation Oncology inc |
$ 149 |
- |
$ -46 |
- |
Sangamo Therapeutics Inc |
$ 148 |
$ 176 |
$ -258 |
411 |
Zura Bio Limited |
$ 147 |
- |
$ -61 |
- |
Molecular Partners Ag |
$ 137 |
$ 7 |
$ -62 |
- |
Vor Biopharma Inc |
$ 130 |
- |
$ -116 |
- |
Armata Pharmaceuticals Inc |
$ 124 |
$ 4 |
$ -60 |
- |
Vigil Neuroscience Inc |
$ 122 |
- |
$ -79 |
- |
Protalix Biotherapeutics inc |
$ 117 |
$ 65 |
$ 8 |
- |
Atyr Pharma Inc |
$ 113 |
$ 10 |
$ -43 |
- |
Bioatla Inc |
$ 112 |
- |
$ -124 |
- |
Titan Pharmaceuticals Inc |
$ 110 |
$ 2 |
$ -6 |
- |
Cel sci Corporation |
$ 99 |
- |
$ -31 |
- |
Jounce Therapeutics inc |
$ 97 |
$ 148 |
$ 0 |
125 |
Athira Pharma Inc |
$ 95 |
- |
$ -121 |
- |
Cardiol Therapeutics inc |
$ 94 |
- |
$ 0 |
- |
Miromatrix Medical inc |
$ 93 |
$ 1 |
$ -32 |
- |
Prokidney Corp |
$ 84 |
- |
$ -222 |
- |
Allovir Inc |
$ 83 |
- |
$ -169 |
- |
Zivo Bioscience Inc |
$ 83 |
- |
$ -8 |
2 |
Passage Bio inc |
$ 80 |
- |
$ -102 |
- |
Genenta Science S p a |
$ 75 |
- |
$ -9 |
- |
Dbv Technologies S a |
$ 74 |
$ 16 |
$ -73 |
- |
Evaxion Biotech A |
$ 73 |
- |
$ -23 |
- |
Champions Oncology Inc |
$ 71 |
$ 49 |
$ -10 |
- |
Logicbio Therapeutics Inc |
$ 68 |
$ 11 |
$ -27 |
- |
Intensity Therapeutics Inc |
$ 66 |
- |
$ 0 |
- |
Ikena Oncology Inc |
$ 65 |
$ 14 |
$ -63 |
- |
Phoenix Biotech Acquisition Corp |
$ 65 |
- |
$ -3 |
- |
Surface Oncology Inc |
$ 65 |
$ 31 |
$ -93 |
- |
Atara Biotherapeutics Inc |
$ 63 |
$ 14 |
$ -290 |
- |
Semper Paratus Acquisition Corporation |
$ 63 |
- |
$ 4 |
- |
Cidara Therapeutics Inc |
$ 63 |
$ 41 |
$ -28 |
- |
Tcr2 Therapeutics Inc |
$ 62 |
- |
$ -163 |
- |
Elutia inc |
$ 62 |
$ 35 |
$ -38 |
- |
Redwoods Acquisition Corp |
$ 58 |
- |
$ 5 |
- |
Avrobio Inc |
$ 57 |
- |
$ -4 |
- |
Cognition Therapeutics inc |
$ 56 |
- |
$ -23 |
- |
Renovacor Inc |
$ 56 |
- |
$ -4 |
- |
Turnstone Biologics Corp |
$ 49 |
- |
$ 0 |
- |
Gamida Cell Ltd |
$ 46 |
- |
$ 79 |
- |
Dyadic International Inc |
$ 46 |
- |
$ 2,482 |
84 |
Greenlight Biosciences Holdings Pbc |
$ 45 |
$ 10 |
$ -157 |
- |
Protara Therapeutics Inc |
$ 45 |
- |
$ -69 |
- |
Achilles Therapeutics Plc |
$ 43 |
- |
$ -71 |
- |
Candel Therapeutics Inc |
$ 40 |
$ 0 |
$ -32 |
- |
Aligos Therapeutics Inc |
$ 40 |
$ 16 |
$ -82 |
- |
Entera Bio Ltd |
$ 39 |
- |
$ 9 |
- |
Pluri Inc |
$ 39 |
$ 0 |
$ -24 |
- |
In8bio Inc |
$ 39 |
- |
$ -30 |
- |
Estrella Immunopharma Inc |
$ 39 |
- |
$ -4 |
- |
Mink Therapeutics Inc |
$ 30 |
- |
$ -25 |
- |
Axcella Health Inc |
$ 30 |
- |
$ -48 |
- |
Nkgen Biotech Inc |
$ 26 |
- |
$ -38 |
- |
Cyclo Therapeutics Inc |
$ 26 |
$ 1 |
$ -20 |
- |
Lexeo Therapeutics Inc |
$ 26 |
- |
$ 0 |
- |
Applied Genetic Technologies Corporation |
$ 26 |
$ 42 |
$ -70 |
- |
Cargo Therapeutics Inc |
$ 20 |
- |
$ 0 |
- |
Aim Immunotech Inc |
$ 18 |
- |
$ -22 |
- |
Senti Biosciences Inc |
$ 18 |
$ 4 |
$ -82 |
- |
Erytech Pharma S a |
$ 18 |
- |
$ -60 |
- |
Acorda Therapeutics Inc |
$ 17 |
$ 111 |
$ -16 |
327 |
Brainstorm Cell Therapeutics inc |
$ 15 |
- |
$ -17 |
- |
Tracon Pharmaceuticals Inc |
$ 13 |
$ 11 |
$ -11 |
- |
Green Planet Bioengineering Co Ltd |
$ 12 |
- |
$ 0 |
- |
Inhibikase Therapeutics Inc |
$ 11 |
$ 0 |
$ -19 |
- |
Aptose Biosciences Inc |
$ 10 |
- |
$ -49 |
- |
Organovo Holdings Inc |
$ 10 |
$ 0 |
$ -19 |
- |
Old Ayala Inc |
$ 8 |
$ 1 |
$ -38 |
- |
Biocardia Inc |
$ 8 |
$ 1 |
$ -13 |
- |
Allena Pharmaceuticals Inc. |
$ 8 |
- |
$ -43 |
- |
Creative Medical Technology Holdings Inc |
$ 7 |
$ 0 |
$ -10 |
- |
Enzon Pharmaceuticals inc |
$ 6 |
$ 2 |
$ 1 |
- |
Sorrento Therapeutics Inc |
$ 6 |
- |
$ 0 |
- |
Rubius Therapeutics Inc |
$ 5 |
- |
$ -180 |
- |
Nanostring Technologies Inc |
$ 5 |
$ 162 |
$ -166 |
721 |
Fresh Tracks Therapeutics Inc |
$ 5 |
$ 10 |
$ -6 |
- |
Finch Therapeutics Group Inc |
$ 4 |
$ 1 |
$ -100 |
- |
Avalon Globocare Corp |
$ 4 |
$ 1 |
$ -9 |
- |
Qrons Inc |
$ 3 |
- |
$ -2 |
- |
Eloxx Pharmaceuticals Inc |
$ 3 |
- |
$ -32 |
- |
Aceragen Inc |
$ 3 |
- |
$ -41 |
- |
Kiromic Biopharma Inc |
$ 3 |
- |
$ -23 |
- |
Palisade Bio Inc |
$ 3 |
- |
$ -13 |
- |
Peak Bio Inc |
$ 2 |
- |
$ -26 |
- |
Clarus Therapeutics Holdings Inc. |
$ 2 |
$ 8 |
$ -23 |
- |
Windtree Therapeutics Inc |
$ 2 |
$ 1 |
$ -25 |
- |
Codiak Biosciences Inc |
$ 1 |
$ 34 |
$ -17 |
- |
Sqz Biotechnologies Company |
$ 1 |
- |
$ 0 |
- |
Polarityte Inc |
$ 1 |
$ 3 |
$ -8 |
- |
Tc Biopharm holdings Plc |
$ 1 |
$ 4 |
$ -1 |
- |
Ladrx Corporation |
$ 1 |
- |
$ 1 |
- |
Zeo Scientifix Inc |
$ 0 |
$ 5 |
$ -6 |
- |
Cannabis Global Inc. |
$ 0 |
$ 4 |
$ -4 |
- |
Genocea Biosciences Inc |
$ 0 |
$ 21 |
$ -37 |
- |
Point Of Care Nano technology Inc |
$ 0 |
- |
$ 0 |
- |
Biontech Se |
- |
$ 540 |
$ 11,528 |
1,700 |
Spk Acquisition Corp |
- |
- |
$ -1 |
- |
Coeptis Therapeutics Holdings Inc |
- |
- |
$ -57 |
- |
Anavex Life Sciences Corp |
- |
$ 3 |
$ -43 |
- |
Forma Therapeutics Holdings Inc. |
- |
- |
$ -190 |
- |
Agentix Corp |
- |
- |
$ -1 |
2 |
10x Capital Venture Acquisition Corp Iii |
- |
- |
$ -1 |
- |
Pharmacyte Biotech Inc |
- |
- |
$ -3 |
- |
Mosaic Immunoengineering Inc |
- |
- |
$ -1 |
- |
Biomx Inc |
- |
- |
$ 27 |
- |
Fennec Pharmaceuticals Inc |
- |
$ 13 |
$ -20 |
- |
Replicel Life Sciences Inc |
- |
- |
$ -1 |
- |
Calidi Biotherapeutics Inc |
- |
- |
$ -29 |
- |
Biondvax Pharmaceuticals Ltd |
- |
- |
$ -1 |
- |
Biotechnology & Pharmaceuticals Industry |
$ 557,263 |
$ 90,442 |
$ 3,935 |
76,397 |
Recent News from Biotechnology & Pharmaceuticals Industry |
Clinical Study
Evaxion Biotech A/S, a leading clinical-stage TechBio company specializing in AI-Immunology powered vaccines, recently held a Research and Development (RandD) Day at its H?rsholm facilities in Denmark. The event aimed to showcase the groundbreaking capabilities of Evaxion's AI-Immunology platform, which holds immense promise in revolutionizing vaccine dev...
|
|
Business Update
In a recent announcement, Scholar Rock, a leading late-stage biopharmaceutical company, shared their financial results and corporate updates for the full year 2023. The company is dedicated to developing innovative treatments for various severe diseases, with a particular focus on spinal muscular atrophy (SMA), cardiometabolic disorders, and conditions wh...
|
|
Pharmacyte Biotech Inc
The Biotechnology and Pharmaceuticals industry insiders have begun to analyze the third-quarter earnings of 2024. As of now, the industry insiders have observed an operating loss of $-1.868946 million from a particular company, which has not yet disclosed any revenue for the period from November to January 31, 2024. In order to provide some context for th...
|
|
Adverum Biotechnologies Inc
Adverum Biotechnologies Inc, a leading biotechnology and pharmaceutical company, has experienced a decrease in its stock by -19.05% in the preceding 30 days. Despite this decline, the year-to-date performance of the company stands at an impressive 105.29%. Currently trading on the NASDAQ, Adverum Biotechnologies Inc's stock is 31.8% above its 52-week aver...
|
|
Zeo Scientifix Inc
Zeo Scientifix Inc has shown promising growth in its recent financial results, despite reporting a deficit per share of $-0.17 for the span ending January 31, 2024. This is a significant improvement from the deficit of $-2.287 million in the same period a year ago. The company's revenue also saw a healthy increase of 7.828% to $1.15 million, showing stron...
|
|
Financing Agreement
Iselin-based biopharmaceutical company, Outlook Therapeutics, has successfully concluded its private placement, securing upfront gross proceeds of approximately $60 million. In addition, the company has the potential to further bolster its financial position with up to $99 million upon the exercise of warrants issued in the private placement. Th...
|
|
Cyclo Therapeutics Inc
Cyclo Therapeutics Inc, a Biotechnology and Pharmaceuticals company, has shown positive growth in the fourth quarter of 2023, despite industry-wide challenges. In its December 31, 2023 report, the company reported a significant revenue rise of 66.699% to $0.31 million. This increase in revenue has helped the company reduce its losses to $-0.18 per share, ...
|
|
Partnership
In a groundbreaking announcement, the McWhorter Family Trust has forged a strategic partnership with Bentley Motors, marking a significant milestone in the realm of automotive excellence. Recognizing Bentley's unrivaled dedication to luxury, innovation, and craftsmanship, the Trust has bestowed the prestigious emblem of automotive distinction upon the ren...
|
|
Product Service News
Scilex Holding Company Addresses Product Composition Questions for ELYXYB Patent in Canada, While Preparing for the Launch of Gloperba and Expanding Its Distribution NetworkPALO ALTO, Calif., March 18, 2024 ?? Scilex Holding Company (Nasdaq: SCLX), a revenue-generating company focused on non-opioid pain management products, has provided responses to Healt...
|
|
Clinical Study
Aligos Therapeutics, a prominent clinical stage biopharmaceutical company, has recently announced the initiation of the Phase 2a HERALD study of ALG-055009 in subjects with metabolic dysfunction-associated steatohepatitis (MASH). The study aims to address the unmet medical needs in liver and viral diseases and is a significant step for Aligos in developin...
|
|
|
|
|
|